Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1683308

CCCCCCCCCCCCCCCCCCCN(CCO)CCO.Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.41
DNM1 Q05193 4/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HSD17B10 Q99714 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.46
GBA1 P04062 1/20 0.43
KDM5A P29375 2/20 0.42
PHF8 Q9UPP1 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
THRB P10828 2/20 0.40
ICMT O60725 1/20 0.39
ALB P02768 1/20 0.39
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4622840 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL10663614 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL28483731 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL5320512 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL2788018 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL9617237 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL10455627 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL1863691 1.00 DNM1 (0.50) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL11789291 0.98 DNM1 (0.48) DNM1LMNAALDH1A1TSHRMEN1
Hydrochloric Acid SCHEMBL11791965 0.98 DNM1 (0.48) DNM1LMNAALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361300-B2 Cost effective ionic liquids such as Choline Saccharinate to electroplate chromium, aluminium, or copper; improved surface finish, with greatly diminished micro-cracking, thinner with good corrosion resistance; environmentally friendly AKZO NOBEL N.V. (NL) 2013-01-29 US claimed
US-20110118121-A1 NOVEL SOLVENTS FOR 2,4-D ACID AND ACID PLANT GROWTH REGULATORS AKZO NOBEL N.V. (NL) 2011-05-19 US claimed
EP-2320722-A2 NOVEL SOLVENTS FOR 2,4-D ACID AND ACID PLANT GROWTH REGULATORS Akzo Nobel N.V. (NL) 2011-05-18 EP claimed
EP-2171131-B1 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS IN THE PRESENCE OF AN ADDITIVE AKZO NOBEL NV (NL) 2010-12-29 EP claimed
US-20100252446-A1 Method to Electrodeposit Metals Using Ionic Liquids in the Presence of an Additive AKZO NOBEL N.V. (NL) 2010-10-07 US claimed
EP-2171131-A1 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS IN THE PRESENCE OF AN ADDITIVE Akzo Nobel N.V. (NL) 2010-04-07 EP claimed
WO-2010003888-A2 NOVEL SOLVENTS FOR 2,4-D ACID AND ACID PLANT GROWTH REGULATORS AKZO NOBEL N.V. (NL) 2010-01-14 WO claimed
US-20090236227-A1 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS AKZO NOBEL N.V. (NL) 2009-09-24 US claimed
WO-2009016189-A1 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS IN THE PRESENCE OF AN ADDITIVE AKZO NOBEL N.V. (NL) 2009-02-05 WO claimed
EP-1984541-A2 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS Akzo Nobel N.V. (NL) 2008-10-29 EP claimed
WO-2007093574-A2 METHOD TO ELECTRODEPOSIT METALS USING IONIC LIQUIDS AKZO NOBEL N.V. (NL) 2007-08-23 WO claimed
US-6548587-B1 Nanocomposites, bottles; poly-m-xylylene adipamide and quaternized montmorillonite clay UNIVERSITY OF SOUTH CAROLINA RESEARCH FOUNDATION 2003-04-15 US claimed
EP-1200515-A1 A POLYAMIDE COMPOSITION COMPRISING A LAYERED CLAY MATERIAL MODIFIED WITH AN ALKOXYLATED ONIUM COMPOUND EASTMAN CHEMICAL COMPANY (US) 2002-05-02 EP claimed
WO-2001004197-A1 A POLYAMIDE COMPOSITION COMPRISING A LAYERED CLAY MATERIAL MODIFIED WITH AN ALKOXYLATED ONIUM COMPOUND EASTMAN CHEMICAL COMPANY (US) 2001-01-18 WO claimed
EP-3573461-B1 ANTIMICROBIAL, NON-THROMBOGENIC POLYMER COMPOSITIONS LUBRIZOL ADVANCED MAT INC (US) 2026-04-22 EP disclosed
EP-4155334-A1 ANTIMICROBIAL THERMOPLASTIC POLYURETHANES Lubrizol Advanced Materials, Inc. (US) 2023-03-29 EP disclosed
US-11578205-B2 Antimicrobial, non-thrombogenic polymer composition LUBRIZOL ADVANCED MATERIALS, INC. (US) 2023-02-14 US disclosed
US-6548587-B1 Nanocomposites, bottles; poly-m-xylylene adipamide and quaternized montmorillonite clay UNIVERSITY OF SOUTH CAROLINA RESEARCH FOUNDATION 2003-04-15 US disclosed
EP-1200515-A1 A POLYAMIDE COMPOSITION COMPRISING A LAYERED CLAY MATERIAL MODIFIED WITH AN ALKOXYLATED ONIUM COMPOUND EASTMAN CHEMICAL COMPANY (US) 2002-05-02 EP disclosed
WO-2001004197-A1 A POLYAMIDE COMPOSITION COMPRISING A LAYERED CLAY MATERIAL MODIFIED WITH AN ALKOXYLATED ONIUM COMPOUND EASTMAN CHEMICAL COMPANY (US) 2001-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118121-A1 NOVEL SOLVENTS FOR 2,4-D ACID AND ACID PLANT GROWTH REGULATORS AP2A2, HACL2, AP2A1 CA2 222/4885DNM1 1762/4885LMNA 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.